Resultats de la cerca - Murphy, Sabina
- Mostrar 1 - 20 resultats de 48
- Anar a la pàgina següent
-
1
Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels: A Meta-analysis per Sabatine, Marc S., Wiviott, Stephen D., Im, KyungAh, Murphy, Sabina A., Giugliano, Robert P.
Publicat 2018Text -
2
-
3
-
4
Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial per Kadakia, Mitul B, Fox, Caroline S, Scirica, Benjamin M, Murphy, Sabina A, Bonaca, Marc P, Morrow, David A
Publicat 2011Text -
5
Influence of Race and Sex on Lipoprotein-Associated Phospholipase A2 Levels: Observations from the Dallas Heart Study per Brilakis, Emmanouil S., Khera, Amit, McGuire, Darren K., See, Raphael, Banerjee, Subhash, Murphy, Sabina A., de Lemos, James A.
Publicat 2007Text -
6
Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 Trial per Scirica, Benjamin M., Sabatine, Marc S., Jarolim, Petr, Murphy, Sabina A., de Lemos, James L., Braunwald, Eugene, Morrow, David A.
Publicat 2011Text -
7
Evaluation of the diagnostic performance of current and next-generation assays for cardiac troponin I in the BWH-TIMI ED Chest Pain Study per Bonaca, Marc P, Ruff, Christian T, Kosowsky, Joshua, Conrad, Michael J, Murphy, Sabina A, Sabatine, Marc S, Jarolim, Petr, Morrow, David A
Publicat 2013Text -
8
Diagnostic Performance of Copeptin in Patients With Acute Nontraumatic Chest Pain: BWH‐TIMI ED Chest Pain Study per Sukul, Devraj, Bonaca, Marc P., Ruff, Christian T., Kosowsky, Joshua, Conrad, Michael, Murphy, Sabina A., Sabatine, Marc S., Jarolim, Petr, Morrow, David A.
Publicat 2014Text -
9
Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain per Vora, Amit N., Bonaca, Marc P., Ruff, Christian T., Jarolim, Petr, Murphy, Sabina, Croce, Kevin, Sabatine, Marc S., Simon, Daniel I., Morrow, David A.
Publicat 2012Text -
10
The prognostic significance of cardiac structure and function in atrial fibrillation: the ENGAGE AF-TIMI 48 Echocardiographic Substudy per Gupta, Deepak K, Giugliano, Robert P, Ruff, Christian T, Claggett, Brian, Murphy, Sabina, Antman, Elliott, Mercuri, Michele F., Braunwald, Eugene, Solomon, Scott D
Publicat 2016Text -
11
Prognostic Evaluation of Catalytic Iron in Patients With Acute Coronary Syndromes per Steen, Dylan L., Cannon, Christopher P., Lele, Suhas S., Rajapurkar, Mohan M., Mukhopadhyay, Banibrata, Scirica, Benjamin M., Murphy, Sabina A., Morrow, David A.
Publicat 2013Text -
12
Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN‐TIMI... per Gutierrez, Jorge A., Karwatowska‐Prokopczuk, Ewa, Murphy, Sabina A., Belardinelli, Luiz, Farzaneh‐Far, Ramin, Walker, Gennyne, Morrow, David A., Scirica, Benjamin M.
Publicat 2015Text -
13
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial per Xu, Haiyan, Ruff, Christian T., Giugliano, Robert P., Murphy, Sabina A., Nordio, Francesco, Patel, Indravadan, Shi, Minggao, Mercuri, Michele, Antman, Elliott M., Braunwald, Eugene
Publicat 2016Text -
14
Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome per Correa, Simon, Morrow, David A., Braunwald, Eugene, Davies, Richard Y., Goodrich, Erica L., Murphy, Sabina A., Cannon, Christopher P., O'Donoghue, Michelle L.
Publicat 2018Text -
15
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38 trial per Murphy, Sabina A., Antman, Elliott M., Wiviott, Stephen D., Weerakkody, Govinda, Morocutti, Giorgio, Huber, Kurt, Lopez-Sendon, Jose, McCabe, Carolyn H., Braunwald, Eugene
Publicat 2008Text -
16
Evaluation of coronary artery calcium screening strategies focused on risk categories: The Dallas Heart Study per Patel, Mahesh J., de Lemos, James A., McGuire, Darren K., See, Raphael, Lindsey, Jason B., Murphy, Sabina A., Grundy, Scott M., Khera, Amit
Publicat 2009Text -
17
Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes per Røysland, Ragnhild, Bonaca, Marc P, Omland, Torbjørn, Sabatine, Marc, Murphy, Sabina A, Scirica, Benjamin M, Bjerre, Mette, Flyvbjerg, Allan, Braunwald, Eugene, Morrow, David A
Publicat 2012Text -
18
Clinical Features, Use of Evidence‐Based Therapies, and Cardiovascular Outcomes Among Patients With Chronic Kidney Disease Following Non–ST‐Elevation Acute Coronary Syndrome per Rhee, June‐Wha, Wiviott, Stephen D., Scirica, Benjamin M., Gibson, C. Michael, Murphy, Sabina A., Bonaca, Marc P., Morrow, David A., Mega, Jessica L.
Publicat 2014Text -
19
Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18 per Morrow, David A., Sabatine, Marc S., Brennan, Marie-Luise, de Lemos, James A., Murphy, Sabina A., Ruff, Christian T., Rifai, Nader, Cannon, Christopher P., Hazen, Stanley L.
Publicat 2008Text -
20
Role of ST2 in Non–ST-Elevation Acute Coronary Syndrome in the MERLIN-TIMI 36 Trial per Kohli, Payal, Bonaca, Marc P., Kakkar, Rahul, Kudinova, Anastacia Y., Scirica, Benjamin M., Sabatine, Marc S., Murphy, Sabina A., Braunwald, Eugene, Lee, Richard T., Morrow, David A.
Publicat 2011Text